Mohammadi Elham, Jayaprakash Geetha, Shiva Afshin, Motallebzadeh Nader
RR College of Pharmacy, Chikkabanavara, Bangalore, India.
Department of Pharmacy Practice, RR College of Pharmacy, Chikkabanavara, Bangalore, India.
Open Access Maced J Med Sci. 2019 Mar 26;7(6):955-958. doi: 10.3889/oamjms.2019.192. eCollection 2019 Mar 30.
In recent years' medical management with misoprostol is an effective alternative to surgical evacuation. But there is a dearth of evidence to reveal the effectiveness of the different routes of misoprostol and satisfaction rate among the patients treated with these routes.
This study was conducted to compare the effectiveness and patient's satisfaction rate of vaginal versus oral misoprostol.
It was a prospective non-interventional study. One hundred women of having missed abortion confirmed by ultrasonography examination were enrolled in the trial. Fifty-eight subjects were administered 200 mcg of oral and 42 subjects received 200 mcg of vaginal misoprostol every four hours up to four doses. If complete expulsion did not occur 12 hours after the last dose, the surgical evacuation was done.
There was no significant statistical difference between the effectiveness of treatment with vaginal (78.57%) and oral misoprostol (79.31%) (p = 0.928). The difference between Patients' satisfaction at the time of discharge for the vaginal group (64.29%) and oral group (65.52%) was not statistically significant (P = 0.991). There was an increase in patients' satisfaction for both groups at the follow-up session, but still, the difference was not significant (P = 0.897).
This study confirms that there is no statistical difference between the effectiveness and patient satisfaction of oral and vaginal misoprostol in the treatment of missed abortion.
近年来,米索前列醇药物治疗是手术清宫的一种有效替代方法。但缺乏证据表明米索前列醇不同给药途径的有效性以及接受这些途径治疗的患者的满意度。
本研究旨在比较阴道给药与口服米索前列醇的有效性及患者满意度。
这是一项前瞻性非干预性研究。纳入100名经超声检查确诊为稽留流产的女性。58名受试者口服200微克米索前列醇,42名受试者阴道给药200微克米索前列醇,每4小时给药一次,最多给药4剂。若最后一剂后12小时仍未完全排出,则进行手术清宫。
阴道给药(78.57%)和口服米索前列醇(79.31%)治疗效果之间无显著统计学差异(p = 0.928)。阴道组(64.29%)和口服组(65.52%)出院时患者满意度差异无统计学意义(P = 0.991)。随访时两组患者满意度均有所提高,但差异仍无统计学意义(P = 0.897)。
本研究证实,口服和阴道给药米索前列醇治疗稽留流产的有效性和患者满意度无统计学差异。